Accent Microcell Ltd was originally incorporated on April 10, 2012, as a Private Limited Company named "Accent Microcell Private Limited." It later converted to a Public Limited Company, changing its name to `Accent Microcell Limited`, and received a Fresh Certificate of Incorporation on December 23, 2022. Prior to the company's incorporation, the promoters operated a similar business as a partnership firm, "M/s Accent Microcell Industries," established in 2002, primarily engaged in manufacturing a variety of excipients. The formation of the company aimed to expand into the pharmaceuticals/excipients sector.
Currently, the company manufactures Microcrystalline Cellulose (MCC), including Spray Dryer / Spin Flash Dried grades. Accent Microcell is engaged in manufacturing high-quality cellulose-based excipients that predominantly find application in the Pharmaceutical, Nutraceutical, Food, Cosmetic, and other industries. AMC is an EXCiPACT, US-DMF, GMP, ISO 9001:2008, HACCP certified manufacturer and exporter of 22 different grades of Microcrystalline Cellulose (MCC). It caters to over 10 sectors and serves more than 200 customers in India and worldwide.
Accent Microcell operates two state-of-the-art manufacturing facilities with a combined capacity of 8,000 metric tonnes:
* Unit I (Pirana, Ahmedabad): Primarily caters to the domestic market, manufacturing MCC, SMCC, PC, and MCC with CMC.
* Unit II (Dahej SEZ, Bharuch): Established as an export-oriented unit ("EOU"), solely engaged in manufacturing MCC, MCC sphere, SMCC, and MCC with CMC for export to overseas customers and distributors.
The company boasts a strong global presence, serving customers from 45 different countries, including key markets such as the US, Canada, Germany, the UK, Japan, China, Australia, Korea, the Netherlands, Turkey, Vietnam, Italy, Indonesia, Poland, Egypt, France, Thailand, New Zealand, Brazil, Russia, Mexico, Chile, Zimbabwe, and Denmark, among others. This extensive reach establishes Accent Microcell as a significant player in the global microcrystalline cellulose market, serving diverse industries across multiple continents.
Accent Microcell Ltd is listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). The Accent Microcell IPO bidding commenced on December 8, 2023, and concluded on December 12, 2023. The allotment was finalized on December 13, 2023, and the shares were listed on NSE SME on December 15, 2023.
Accent Microcell has demonstrated strong financial performance with consistent growth patterns:
* Market Capitalization: ₹646.98 Crore as of July 7, 2025.
* Revenue (TTM): ₹373.97 Crore.
* Profit (TTM): ₹30 Crore.
* Historical Growth:
* Over the last 5 years, revenue has grown at a yearly rate of 14.89%, outperforming the industry average of 10.14%.
* Over the last 5 years, net income has grown at a yearly rate of 51.23%, significantly higher than the industry average of 20.01%.
* The company has delivered a good profit growth of 51.2% CAGR over the last 5 years.
Key Financial Metrics:
* Operating Revenue (TTM): ₹373.97 Cr.
* Annual Revenue Growth: 20% (outstanding).
* Pre-tax Margin: 15% (great).
* ROE: 18% (exceptional).
* TTM Profit After Tax: ₹30 Cr.
* 52-Week High: ₹297.96
* 52-Week Low: ₹170.26
* P/E (Price-to-Earnings) Ratio: 19.57 (as of [not specified, but implied from context]), 16.67 times as on 06-Jun-2025 (a 58% discount to its peers' median range of 39.70 times).
* P/B (Price-to-Book) Ratio: 3.95 (as of [not specified]), 2.71 times as on 06-Jun-2025 (a 27% discount to its peers' median range of 3.72 times).
* Chairman: Vasant Vadilal Patel
* Managing Director: Ghanshyam Patel
* Company Secretary: Braham Pal Chhabra
Promoter holding in Accent Microcell Ltd increased to 55.09% as of September 2024, from 53.67% as of December 2023, indicating management confidence.
The company demonstrates strong financial health:
* Debt Position: Almost debt-free with a reasonable debt-to-equity ratio of 1%, signaling a healthy balance sheet.
* Promoter Pledging: No promoter pledging in Accent Microcell Ltd.
* July 11, 2025: Exempted from Q1 2025 Corporate Governance Report under SEBI SME rules. Submission of SEBI Reg 74(5) compliance certificates for the quarter ended June 30, 2025.
* July 8, 2025: Trading approval received for 29.46 lakh shares allotted via rights issue at ₹135 each.
* Dividend: In the quarter ending March 2024, Accent Microcell Ltd declared a dividend of ₹1, translating to a dividend yield of 0.44%.
Accent Microcell Ltd stands as a well-established player in the pharmaceutical excipients industry with strong fundamentals, an impressive growth trajectory, and a robust global presence. The company's focus on quality manufacturing and international expansion positions it well for continued growth in the expanding pharmaceutical and nutraceutical sectors.
